...
首页> 外文期刊>Annals of surgical oncology >Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management.
【24h】

Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management.

机译:胃肠道间质瘤:当前的诊断,生物学行为和管理。

获取原文
获取原文并翻译 | 示例

摘要

Gastrointestinal stromal tumors (GIST) are rare tumors of the gastrointestinal (GI) tract that arise from primitive mesenchymal cells. GISTs occur throughout the GI tract but are usually located in the stomach and small intestine. The majority of GISTs are immunohistochemically positive for c-kit protein (CD 117) and CD34. GISTs express a heterogeneous clinical course not easily predicted by standard pathological means. The most important prognostic factors are size > 5 cm, tumor necrosis, infiltration and metastasis to other sites, mitotic count > 1-5 per 10 high-powered fields, and most recently, mutation in the c-kit gene. Surgical resection remains the mainstay of treatment, as chemotherapy and radiation are ineffective. Long-term follow-up is imperative, as recurrence rates are high.
机译:胃肠道间质瘤(GIST)是由原始间充质细胞引起的胃肠道(GI)道罕见肿瘤。 GISTs遍及整个胃肠道,但通常位于胃和小肠中。大多数GIST对c-kit蛋白(CD 117)和CD34免疫组织化学阳性。 GISTs表达的异质临床病程很难通过标准病理学手段预测。最重要的预后因素是肿瘤大小> 5 cm,肿瘤坏死,浸润和转移到其他部位,有丝分裂计数> 1-5 / 10个高倍视野,以及最近的c-kit基因突变。手术切除仍然是治疗的主要手段,因为化学疗法和放射疗法无效。由于复发率很高,因此必须进行长期随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号